Humanigen Inc (fka HGENQ)

[DonDonDonDon]

So promising GILD walked away.

Humanigen walked away. And it is promising. The trial showed that lenzilumab is effective with Gilead's Yescarta but now lenz will now be trialed in combination with every CAR-T treatment that is commercially available. If it is effective with multiple CAR-T therapies, which is likely since all of their toxicity issues stem from GM-CSF, the buyout price will be astronomical. Lenzilumab might literally make CAR-T viable.